Urothelial Cancers

• Neutrophil-to-lymphocyte ratio is a useful biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated...
• Long-term outcomes of bladder preservation in muscle-invasive bladder cancer patients
• An outcome analysis of robotassisted radical nephroureterectomy with extended template lymphadenectomy for upper tract urothelial carcinoma
• Metastatic carcinoma gall bladder: A clinicoepidemiological profile of Indian patients
• Comparative analysis of first-line immune checkpoint inhibitor versus carboplatin-based chemotherapy for cisplatin-ineligible metastatic urothelial...
• EV-301: A phase III trial in progress evaluating enfortumab vedotin versus chemotherapy in patients with locally advanced or metastatic urothelial...
• Urachal Adenocarcinoma: Case Report
• Concurrent Atezolizumab-Radiotherapy in Locally Recurrent Urinary Bladder Carcinoma: A Case Report
• The evolving IO treatment landscape in UC
• Molecular dissection on bladder cancer
• Discussion led by moderator
• High incidence and mortality of transitional cell carcinoma in Thai kidney transplant patients
• Bladder
• 11th European Multidisciplinary Congress on Urological Cancers
• Participant Clinical Case Discussion: Meningism in a patient with Urothelial Cancer "When you have excluded the impossible.."
• Invited Discussant LBA14_PR
• IMvigor130: efficacy and safety from a Phase 3 study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs p...
• Pathologic outcomes after neoadjuvant chemotherapy for high-risk muscle invasive bladder cancer
• Potential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based...
• Hyperphosphatemia due to Erdafitinib (a Pan-FGFR Inhibitor) and Anti-tumor Activity Among Patients (Pts) with Advanced Urothelial Carcinoma (UC)
• Prognostic role of FGFR Mutations and FGFR mRNA expression in metastatic urothelial cancer treated with anti-PD(L1) inhibitors in first and second...
• Comparative analysis of tumor mutational burden (TMB) prediction methods and its association with determinants of the tumor immune microenvironment...
• The Immunoscore in patients with urothelial carcinoma treated with neoadjuvant chemotherapy: clinical significance for pathological response and su...
• Genomic analysis of urothelial cancer and associations with treatment choice and outcome
• A differential bladder microbiota composition is associated with tumor grade in bladder cancer.

• « Previous
• 1
• 2
• ...
• 15
• Next »